Panacea Biotec Limited has informed the Exchange about Bagging/Receiving of orders/contracts from Central Medical Services Society, Ministry of Health and Family Welfare, Government of India ( CMSS ) for supply of Diphtheria and Tetanus Vaccine (Absorbed) for Adults and Adolescents IP ( Td Vaccine ) in several tranches to CMSS for the value aggregating to INR 20.79 Crore.
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Panacea Biotec has received a Letter of Award dated April 10, 2026 from the Central Medical Services Society (CMSS), which comes under the Ministry of Health and Family Welfare, Government of India. The company will supply Diphtheria and Tetanus Vaccine (Td Vaccine) for Adults and Adolescents in multiple tranches from September/October 2026 through November/December 2028. The total contract value is INR 20.79 Crore. This is a domestic supply order with no related party involvement. The order represents a healthcare-focused government procurement contract for routine immunization supplies.
This order provides revenue visibility over a multi-year period (2026-2028) from a government customer, which is positive for the company's order book. However, the amount of INR 20.79 Crore is relatively modest for a pharmaceutical company of Panacea Biotec's scale.